Travere Therapeutics, Inc. ( TVTX) - Key Metrics
TVTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.44 | -$0.24 | $0.67 | $0.68 |
| 2025Q3 | $1.85 | $0.29 | $0.16 | $0.16 |
| 2025Q2 | $1.29 | -$0.14 | $0.06 | $0.05 |
| 2025Q1 | $0.93 | -$0.47 | -$0.48 | -$0.61 |
TVTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -39.23 |
| 2025Q3 | ? | 20.74 |
| 2025Q2 | ? | -25.80 |
| 2025Q1 | ? | -9.60 |
TVTX
Price: $53.80
52 week price:
Earnings Per Share: -0.50 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Market Capitalization: 4.3 billion